Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
InSightec clinical trials
The registry lists 84 studies whose lead sponsor is InSightec. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.
Get an email when these change. Save the InSightec studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to InSightec.
- InSightec84 studiesSame company
Something wrong?
Focus areas
Conditions InSightec leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 →
- Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.Not yet recruitingNCT07764874Not applicable
- Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain MetsRecruitingNCT05317858Phase 3
- EMBRACE Tremor BiFUSRecruitingNCT06974916Not applicable
- A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult SubjectsRecruitingNCT03028246Not applicable
- Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)RecruitingNCT04197921Not applicable
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's DiseaseRecruitingNCT04991831
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsRecruitingNCT05539196
- ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseRecruitingNCT03671889Not applicable
- Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine FibroidsRecruitingNCT05386615
- MR-guided Focused Ultrasound Plus GCaseActive, not recruitingNCT05565443Not applicable
- MRI-Guided Focused Ultrasound Feasibility Study for Brain TumorsActive, not recruitingNCT00147056Not applicable
- ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's DiseaseCompletedNCT02347254Not applicable
- Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused UltrasoundCompletedNCT02343991Not applicable
- Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast CarcinomasCompletedNCT02794558Not applicable
- Study of ExAblate Focused Ultrasound Ablation of Breast CancerCompletedNCT01620359Phase 2
- Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential TremorCompletedNCT03935581Not applicable
- ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's DiseaseCompletedNCT02246374Not applicable
- Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's DiseaseCompletedNCT04002596Not applicable
- A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's DiseaseActive, not recruitingNCT06584383Not applicable
- Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)WithdrawnNCT05089786Not applicable
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPGActive, not recruitingNCT05615623Phase 1/2
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)Active, not recruitingNCT05630209Phase 1/2
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM PatientsCompletedNCT04998864
- A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor FeaturesCompletedNCT03454425Not applicable
- Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's DiseaseCompletedNCT04370665Not applicable
- A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PDCompletedNCT03964272Not applicable
- Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain MetastasesCompletedNCT03714243Not applicable
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionCompletedNCT03551249Not applicable
- Study of MRgFUS Exablate Treatment Following the Neuropathic PainTerminatedNCT04649554Not applicable
- A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease DementiaCompletedNCT03608553Not applicable
- Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral SclerosisCompletedNCT03321487Not applicable
- Staged Bilateral Exablate Treatment of Medication Refractory Essential TremorCompletedNCT03465761Not applicable
- Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin MonotherapyCompletedNCT04417088Phase 1/2
- ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's DiseaseActive, not recruitingNCT03319485Not applicable
- ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's DiseaseCompletedNCT03739905Not applicable
- Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBMCompletedNCT04440358Phase 1/2
- Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsCompletedNCT05383872Not applicable
- Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:Active, not recruitingNCT03100474
- Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating GliomaWithdrawnNCT04667715Not applicable
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement DisordersActive, not recruitingNCT02252380Not applicable
- Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsActive, not recruitingNCT03998657Not applicable
- Bilateral Treatment of Medication Refractory Essential TremorActive, not recruitingNCT04112381Not applicable
- ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain TumorsActive, not recruitingNCT01473485Not applicable
- Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)Active, not recruitingNCT04728295Not applicable
- Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate LesionsCompletedNCT01657942Not applicable
- ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential TremorsCompletedNCT01827904Not applicable
- Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential TremorsCompletedNCT02289560Not applicable
- A Clinical Trial for the Safety and Effect of MRGuided FUS Subthalamotomy for Medication Refractory Parkinson's DiseaseCompletedNCT04744493Not applicable
- ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard ChemotherapyCompletedNCT03712293Not applicable
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of GliomaCompletedNCT03616860Not applicable